Navigation Links
Bionovo Reports Third Quarter 2008 Financial Results
Date:11/3/2008

EMERYVILLE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced results for the third quarter of 2008.

Quarter Results

The company did not report any revenue for the three and nine months ended September 30, 2008.

Total operating expenses for the three and nine months ending September 30, 2008 were $5.2 million and $13.7 million, respectively, compared to $3.6 million and $9.9 million, respectively, for the same period in 2007. This reflects the increase in costs related to the clinical trials of our leading drug candidates.

The Company reported a net loss for the three and six months ended September 30, 2008 of $5.1 million, or $0.07 per share, and $13.2 million, or $0.17 per share, respectively, compared with a net loss of $3.2 million, or $0.05 per share, and $9.2 million, or $0.15 per share, respectively, for the same periods in 2007.

The Company ended the quarter with $17.3 million in cash, cash equivalents and short term investments, and began the quarter with $24.6 million, a difference of $7.3 million. This difference includes $3.4 million in non- recurring capital expenditures associated with tenant improvements for laboratory and production capability expansion.

Company Highlights

The Company has continued the scientific and clinical development of its drug candidates for the treatment of advanced breast cancer, menopausal hot flashes, and menopausal vaginal atrophy. Recent advances have included:

-- The Phase 1 portion of the BZL101 Phase 1/2 clinical trial for

advanced metastatic breast cancer has now been completed

successfully, showing positive safety and tolerability profiles, as

well as the e
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  Replikins Ltd. today released new ... Ebola virus. Before the current outbreaks, the mean Ebola ... amino acids) between 1995 and 2002 was 1.1; the ... 2012, and sixteen-fold in 2013, thus predicting the current ... technology has been shown to be able to predict ...
(Date:7/30/2014)... Sales Horizons, a leader in sales ... training programs for companies engaged in complex B2B sales. ... thousands of salespeople over 25 years in market-leading Fortune ... be customized to address the unique sales challenges of ... training program consists of two parts: Mastering the ...
(Date:7/30/2014)... BROOK, NY (PRWEB) July 30, 2014 ... APDN), (Twitter: @APDN), a biotechnology firm that provides DNA-based ... Michael E. Hogan, Ph.D. Vice President of Life Sciences, ... mid-September. , Dr. Hogan will lead APDN’s ... form business relationships with biotech and healthcare customers, provide ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Yuma ... facility and complementary therapies brings comprehensive cancer care ... state-of-the-art Yuma Regional Cancer Center has officially opened. ... the program includes services such as open, semi-private ... therapy, American Cancer Society Resource Center, hematology, rehabilitation ...
Breaking Biology Technology:Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2
... 2011 Zacharon Pharmaceuticals, Inc. today announced that ... collaboration with Pfizer Inc. to develop drugs for ... value of the collaboration to Zacharon is approximately ... development of compounds that may be discovered using ...
... as well as students working in micro-electromechanical systems ... developing common MEMS fabrication processes. A fundamental, comprehensive ... to be an important game-changing asset for the ... Handbook is an exhaustive design reference for researchers ...
... and DANVILLE, Pa., April 6, 2011 Definiens, the ... life sciences firm specializing in advanced cancer diagnostics, today ... tool for the diagnosis of cancer. Cernostics will apply ... tests for the treatment of a variety ...
Cached Biology Technology:Zacharon Pharmaceuticals Announces Research and Development Collaboration With Pfizer to Develop Drugs for Multiple Rare Disorders 2Zacharon Pharmaceuticals Announces Research and Development Collaboration With Pfizer to Develop Drugs for Multiple Rare Disorders 3MEMS Materials and Processes Handbook -- a comprehensive, practical resource 2Definiens and Cernostics Partner to Develop Multiplexed Cancer Diagnostic Tests 2Definiens and Cernostics Partner to Develop Multiplexed Cancer Diagnostic Tests 3
(Date:7/30/2014)... JOSE, Calif. , July 30, 2014 /PRNewswire/ ... partnership with the United States Air Force Research ... proposed by Binghamton University ... human performance monitoring (HPM). The $425,000 project, with ... electronics packaging firm i3 Electronics, Inc. ( ...
(Date:7/29/2014)... the University of Bristol,s Nutrition and Behaviour Unit (NBU) ... account when planning meals. , The research, to be ... Behavior Conference (SSIB 2014) in Seattle, USA this week ... , The team was led by Professor Jeff Brunstrom, ... , As part of a Biotechnology and Biological Sciences ...
(Date:7/29/2014)... of science, researchers sometimes need to get back ... just that to study the impacts of the ... reef ecosystems at two remote locations in the ... tracking and computer simulation, McCauley, an assistant professor ... Biology, and his colleagues sought to understand whether ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 2Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 3Underwater elephants 2Underwater elephants 3
... of food poisoning from the food chain is the aim ... Research Council (BBSRC) and the world-leading UK-based poultry breeding company ... cases of food poisoning a year in England and Wales ... 600 million a year. It is usually passed to humans ...
... Feb. 15, 2012 /PRNewswire-iReach/ -- The ... Groupware Collaborative, announced a new round of speakers and ... Forum , part of HIMSS12 on February 23, 2012 ... exhibition from the Healthcare Information and Management Systems Society ...
... airborne laser technology, satellite mapping, and ground-based plot surveys, ... high-resolution estimates of carbon stocks in remote and fragile ... to map carbon stocks in rugged geographic regions and ... employed to support conservation and climate-change mitigation under the ...
Cached Biology News:New research to help eliminate most common food poisoning bug 2Collaborative Health Consortium Announces eCollaboration Forum Final Agenda for HIMSS 2012 2Collaborative Health Consortium Announces eCollaboration Forum Final Agenda for HIMSS 2012 3 Super high-resolution carbon estimates for endangered Madagascar 2